Literature DB >> 32647438

Rifampin Induced Thrombotic Thrombocytopenic Purpura.

Hannah Hamad1, Kamal Kant Sahu1,2, Steven Dunn1, Lucia Milla1, Alice Caffery1, Nahida Islam3.   

Abstract

Entities:  

Year:  2020        PMID: 32647438      PMCID: PMC7326874          DOI: 10.1007/s12288-019-01249-9

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  8 in total

1.  Thrombotic thrombocytopenic purpura due to rifampicin.

Authors:  I H Fahal; P S Williams; R E Clark; G M Bell
Journal:  BMJ       Date:  1992-04-04

2.  Cross-reaction to rifabutin after rifampicin induced flu-like syndrome and thrombocytopenia.

Authors:  Keat Choong; David Looke
Journal:  Scand J Infect Dis       Date:  2010-09-20

3.  Rifampin-induced thrombotic thrombocytopenic purpura.

Authors:  Rahul Gupta; Kurt A Wargo
Journal:  Ann Pharmacother       Date:  2005-09-06       Impact factor: 3.154

4.  The return of Koch's: Ineffective treatment or re-infection.

Authors:  Amos Lal; Ajay Kumar Mishra; Kamal Kant Sahu; George M Abraham
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2019-07-12

5.  Cortical vein thrombosis in a case of idiopathic thrombocytopenic purpura.

Authors:  Kamal Kant Sahu; Subhash Chander Varma
Journal:  Platelets       Date:  2014-03-28       Impact factor: 3.862

6.  Immune Thrombocytopenia as a Presenting Manifestation of Tuberculosis- Challenge in Resource Constraint Settings.

Authors:  Deba Prasad Dhibar; Kamal Kant Sahu; Varun Dhir; Surjit Singh
Journal:  J Clin Diagn Res       Date:  2016-10-01

7.  Splenic sequela of babesiosis.

Authors:  K K Sahu; N Petrou; Z Cohn; V Bathini
Journal:  QJM       Date:  2020-08-01

8.  Hematological and liver toxicity of anti-tuberculosis drugs.

Authors:  Maryam-Sadat Mirlohi; Alireza Ekrami; Saeed Shirali; Mehdi Ghobeishavi; Fatemeh Pourmotahari
Journal:  Electron Physician       Date:  2016-09-20
  8 in total
  1 in total

Review 1.  Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19.

Authors:  Xin Wang; Kamal Kant Sahu; Jan Cerny
Journal:  J Thromb Thrombolysis       Date:  2020-10-15       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.